Cancer man cancer woman
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Gender Disparities in Cancer: A Comparative Analysis of Men and Women
Cancer Incidence and Mortality Trends
Rising Cancer Incidence in Men and Women
In 2023, the United States is projected to see 1,958,310 new cancer cases and 609,820 cancer deaths. Notably, cancer incidence trends show a gender disparity. Prostate cancer in men has seen a 3% annual increase from 2014 to 2019, while lung cancer in women decreased at half the pace of men (1.1% vs. 2.6% annually) from 2015 to 2019. Additionally, breast and uterine corpus cancers continue to rise in women, whereas liver cancer and melanoma have stabilized or declined in men aged 50 and older.
Decline in Cancer Mortality Rates
Despite the COVID-19 pandemic, cancer mortality rates have continued to decline, contributing to a 33% overall reduction since 1991. This progress is largely due to advances in treatment, particularly for leukemia, melanoma, and kidney cancer, which have seen rapid declines in mortality despite stable or increasing incidence rates.
Gender Differences in Lung Cancer Survival
Better Survival Rates for Women
Studies have shown that women with non-small cell lung cancer (NSCLC) have better survival rates than men. Women tend to be younger, present at an earlier stage, and have a higher incidence of adenocarcinoma. The 5-year survival rate for women with stage I to III NSCLC is significantly higher than for men, with women also responding better to neoadjuvant chemotherapy.
Male Breast Cancer: A Rare but Significant Concern
Epidemiology and Risk Factors
Male breast cancer is rare, accounting for less than 1% of all breast cancer cases. The incidence has remained stable over the past four decades, with approximately 1,500 new cases and 400 deaths annually in the United States. Risk factors include genetic predispositions such as BRCA2 mutations, testicular dysfunction, and conditions like Klinefelter syndrome. Men with a family history of breast cancer or Jewish ancestry also have a higher risk .
Clinical Management and Treatment
Men with breast cancer are more likely to undergo mastectomy and receive radiation therapy post-surgery compared to women. However, they are less likely to receive chemotherapy. The treatment protocols for male breast cancer are often extrapolated from female breast cancer data, but there are important biological differences, such as a higher rate of hormone receptor positivity in men .
Genetic Landscape and Molecular Differences
Genetic Predispositions
Pathogenic variants in cancer-predisposing genes play a significant role in male breast cancer. BRCA2 mutations are particularly prevalent, with a lifetime risk of 6.8% for men harboring these mutations. Other genes like PALB2 and CHEK2 have also been associated with increased risk. Despite the genetic similarities, male breast cancer has distinct molecular characteristics compared to female breast cancer.
Conclusion
Cancer incidence and mortality trends reveal significant gender disparities, with men experiencing rising rates of prostate cancer and women facing increasing breast and uterine corpus cancers. Survival rates for lung cancer are better in women, and male breast cancer, though rare, presents unique clinical challenges and genetic predispositions. Understanding these differences is crucial for developing gender-specific treatment strategies and improving outcomes for both men and women.
Sources and full results
Most relevant research papers on this topic